GSK Profit Beats Estimates on HIV, Cancer Medicines
✨ AI Summary
🔊 جاري الاستماع
GSK Plc’s profit was higher than analysts expected in the first quarter, helped by the drugmaker’s specialty medicines for HIV, cancer and immune diseases.
